Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 04, 2026
TickeronGET DAILY SIGNALS
Nutrien (NTR) Q3 Earnings: EPS Shortfall Offset by Strategic Portfolio Adjustments

Nutrien (NTR) Q3 Earnings: EPS Shortfall Offset by Strategic Portfolio Adjustments

Key Takeaways

  • Nutrien reported third-quarter 2026 adjusted earnings of $0.61 per share, below the consensus estimate of roughly $0.80 per share.
  • Net earnings fell 39% year over year to $288 million, while adjusted EBITDA declined 8% to $1.31 billion.
  • Total sales rose 1% to $6.06 billion, modestly ahead of analyst expectations near $5.79 billion.
  • Phosphate adjusted EBITDA plunged 93% to just $8 million as surging sulfur input costs compressed margins.
  • Nutrien plans to close its higher-cost White Springs, Florida, phosphate facility in the second quarter of 2027 and expects fourth-quarter impairment charges of about $430 million (White Springs) and $760 million (Trinidad nitrogen).
  • Full-year guidance was updated, with lower Retail adjusted EBITDA and capital spending but higher potash and nitrogen sales-volume targets.
  • For additional context on this ticker, explore NTR's Major News, Today's Price Move, Price Targets, and Forecasts on Tickeron's dedicated pages.
  • Explore Trending AI Robots to discover AI-driven trading strategies built for today's market.

Why These Results Matter

As one of the world’s largest producers of potash, nitrogen, and phosphate fertilizers plus a significant agricultural retailer, NTR sits at the crossroads of global nutrient pricing and farm-level demand. Its quarterly updates give investors a clear window into fertilizer benchmarks, grower buying patterns, and pressures from inputs such as natural gas and sulfur. The third quarter unfolded against steady potash fundamentals and tighter nitrogen markets, yet sulfur costs climbed and North American demand softened. Beyond the numbers, management’s review of the Phosphate business points to a sharper emphasis on earnings quality and free cash flow.

Breaking Down the Reported Figures

For the three months ended September 30, 2026, NTR recorded net earnings of $288 million, down 39% from $469 million a year earlier, with diluted net earnings per share of $0.60 versus $0.96. Adjusted net earnings per share reached $0.61, a 37% decline and below the consensus estimate of about $0.80, according to LSEG data. Total sales edged up 1% to $6.06 billion, slightly above expectations near $5.79 billion.

Adjusted EBITDA fell 8% to $1.31 billion, led by softness in Phosphate and Nitrogen. Phosphate adjusted EBITDA dropped 93% to $8 million after sulfur-driven cost of goods sold rose to $939 per tonne. Nitrogen adjusted EBITDA declined 11% to $497 million on a 16.7% drop in sales volumes. Potash adjusted EBITDA held essentially flat at $730 million, while Retail adjusted EBITDA eased 12% to $203 million on lower crop-nutrient margins. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

On guidance, Nutrien lowered its 2026 Retail adjusted EBITDA range to $1.72–$1.85 billion and trimmed capital expenditures to $1.95–$2.00 billion, while lifting potash sales-volume guidance to 14.3–14.8 million tonnes and nitrogen volumes to 9.3–9.7 million tonnes.

Market Reaction and Investor Sentiment

Despite the earnings miss, the market focused on NTR’s shift toward cost discipline and free cash flow. The decision to close the higher-cost White Springs facility while optimizing the lower-cost Aurora operations was presented as a step to improve earnings quality. Analysts highlighted the potential for stronger free cash flow, supported by lower capital spending and higher potash volume targets.

Sentiment reflected a balance between near-term margin pressure from sulfur and nitrogen costs and longer-term benefits from portfolio simplification. The company also flagged expected fourth-quarter impairment charges against White Springs and the idled Trinidad nitrogen assets, underscoring that restructuring costs could still affect reported results even as the underlying cash-generation profile improves.

Forward Outlook and Factors to Watch

Looking ahead, attention will turn to whether these cost actions deliver structurally higher free cash flow per share. The White Springs closure, expected in the second quarter of 2027, should reduce annual sustaining capital expenditures and lease payments by roughly $50 million. Management also pointed to higher ammonia operating rates and debottlenecking to support nitrogen volumes in the fourth quarter.

Global potash fundamentals remain a key variable. Nutrien kept its forecast for 74–77 million tonnes of global potash shipments in 2026 and projects 75–79 million tonnes in 2027, backed by favorable affordability and solid demand in major importing regions.

On the cost front, sulfur feedstock availability and pricing will stay critical for Phosphate, while natural gas costs and trade flows will continue to shape nitrogen economics. Grower demand in North America, Brazil, and Australia, along with weather and credit conditions, will influence the Retail segment.

Finally, the updated guidance ranges and the effective tax rate increase to 25.5–27.0% highlight how changes in geographic earnings mix can affect adjusted results. As the company advances its portfolio optimization, the market is likely to focus more on the path of free cash flow and shareholder returns than on headline earnings swings.

Using Tickeron’s AI Screener for Deeper Analysis

One tool I turn to regularly when reviewing earnings reports like this is Tickeron’s AI Screener. It lets me filter thousands of stocks and ETFs by technical patterns, fundamentals, trends, and volatility, helping surface comparable ideas in the fertilizer space and monitor momentum shifts more efficiently than manual methods.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: NTR

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


NTR's RSI Oscillator ascending out of oversold territory

The RSI Indicator for NTR moved out of oversold territory on October 12, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 24 similar instances when the indicator left oversold territory. In 20 of the 24 cases the stock moved higher. This puts the odds of a move higher at 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on NTR as a result. In 55 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.

The Moving Average Convergence Divergence (MACD) for NTR just turned positive on October 23, 2026. Looking at past instances where NTR's MACD turned positive, the stock continued to rise in 29 of 50 cases over the following month. The odds of a continued upward trend are 58%.

Following a +2.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where NTR advanced for three days, in 229 of 321 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The 10-day moving average for NTR crossed bearishly below the 50-day moving average on October 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 67%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NTR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.

NTR broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for NTR entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. NTR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.328) is normal, around the industry mean (-0.427). P/E Ratio (14.589) is within average values for comparable stocks, (8.568). NTR's Projected Growth (PEG Ratio) (1.982) is slightly higher than the industry average of (0.867). Dividend Yield (0.031) settles around the average of (0.130) among similar stocks. P/S Ratio (1.329) is also within normal values, averaging (1.476).

The Tickeron SMR rating for this company is 73 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 78 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 84 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NTR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.

Notable companies

The most notable companies in this group are CF Industries Holding (NYSE:CF), Mosaic Company (The) (NYSE:MOS).

Industry description

The agricultural chemicals sector includes companies that produce chemical products for the agricultural industry applications like crop protection, animal health, biotechnology and pharmaceutical-related products. Some of the largest agricultural chemicals producers include Nutrien Ltd., Corteva Inc., and FMC Corporation.

Market Cap

The average market capitalization across the Chemicals: Agricultural Industry is 5.88B. The market cap for tickers in the group ranges from 611 to 34.39B. NTR holds the highest valuation in this group at 34.39B. The lowest valued company is BHILQ at 611.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Agricultural Industry was 4%. For the same Industry, the average monthly price growth was -12%, and the average quarterly price growth was -15%. FMC experienced the highest price growth at 44%, while AVD experienced the biggest fall at -14%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Agricultural Industry was 51%. For the same stocks of the Industry, the average monthly volume growth was -68% and the average quarterly volume growth was 20%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 36
P/E Growth Rating: 61
Price Growth Rating: 61
SMR Rating: 80
Profit Risk Rating: 79
Seasonality Score: -34 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a producer of fertilizers and other crop production supplies

Industry ChemicalsAgricultural

Industry
Chemicals Agricultural
Address
211 19th Street East
Phone
+1 306 933-8500
Employees
25100
Web
https://www.nutrien.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
FET shares plunged 8.55% to $57.50 from the previous close of $62.87 during today's trading session. The sell-off followed the release of first-quarter 2026 earnings, which beat EPS and revenue estimates at $0.47 versus $0.44 expected.
Xerox Holdings Corporation (XRX) stock price surged +114% over the past 30 days, driven primarily by a strong Q1 2026 revenue beat from the Lexmark acquisition. Over the past quarter, XRX is up +17%, recovering from mid-period lows amid volatile trading and financial concerns.